Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IntermesticTSE:262A -1.68%16 FCF Margin % is 0.00% as of Jun. 2026. GuruFocus rates TSE:262A with a GF Score™ of 16/100. The stock has 4 warning signs investors should review. Among 813 Medical Devices & Instruments companies, Intermestic ranks better than 62.85% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Intermestic's Free Cash Flow for the
three
months ended in Jun. 2026 was 円0 Mil. Intermestic's Revenue for the
three
months ended in Jun. 2026 was 円0 Mil. Therefore, Intermestic's FCF Margin % for the quarter that ended in Jun. 2026 was 0.00%.
The historical rank and industry rank for Intermestic's FCF Margin % or its related term are showing as below:
TSE:262A'
s FCF Margin % Range Over the Past 10 Years
Min: 3.03 Med: 5.8 Max: 10.89
Current: 4.95
During the past 4 years, the highest FCF Margin % of Intermestic was 10.89%. The lowest was 3.03%. And the median was 5.80%.
TSE:262A's FCF Margin % is ranked better than 62.85% of 813
companies
in the Medical Devices & Instruments industry
Industry Median: -0.71
vs TSE:262A: 4.95
The historical data trend for Intermestic's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:262A vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Intermestic's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intermestic FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Intermestic's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Intermestic's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intermestic (TSE:262A) has a FCF Margin % of 0.00% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Intermestic and its competitors. Over the past decade, Intermestic's FCF Margin % has ranged from 3.03 to 10.89. According to the industry distribution chart, Intermestic ranks #302 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 37.1%.
Is Intermestic's FCF Margin % too high?
Intermestic's current FCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 3.03 to a high of 10.89. Based on the distribution chart, Intermestic ranks #302 out of 813 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Intermestic has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Intermestic's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Intermestic ranks #302 out of 813 companies for FCF Margin %. This puts Intermestic in the upper half of its industry. Historically, Intermestic's own FCF Margin % has ranged from 3.03 to 10.89 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Intermestic and its competitors. Intermestic's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intermestic stock overvalued right now?
Intermestic (TSE:262A) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Intermestic's overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Intermestic (TSE:262A), the current FCF Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:262A has been successfully added to your 
